ADMA supply chain intelligence for ADMA Biologics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
ADMA Biologics, Inc. (ADMA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| GRIFOLS-WORLDWIDE-OPERATIONS-LIMITED | GRIFOLS-WORLDWIDE-OPERATIONS-LIMITED | 92% | Pursuant to the A&R Grifols Agreement, Grifols supplies, on a non-exclusive basis, to ADMA BioManufacturing a minimum of 35,000 liters of RSV plasma annually to be used in the manufacture of ASCENIV. |
| GENESISBPS | GENESISBPS | 90% | The Company purchased source plasma from GenesisBPS in the amount of approximately $ 34,000. |
| ARCC | Ares Capital Corporation | 72% | Reciprocal relationship from ARCC graph: Reciprocal relationship from ADMA graph: Reciprocal relationship from ARCC graph: Reciprocal relationship from ADMA graph: Reciprocal relationship from ARCC g… |
| STT-PG | State Street Corporation | 72% | tive tax rates. We may be subject to audits of our income, sales, and other transaction taxes by U.S. federal, state, and local taxing authorities. Outcomes from these audits could have a material ef… |
| STT-PG | State Street Corporation | 72% | Reciprocal relationship from STT-PG graph: Reciprocal relationship from ADMA graph: Reciprocal relationship from STT-PG graph: Reciprocal relationship from ADMA graph: Reciprocal relationship from ST… |
| KMDA | Kamada Ltd. | 62% | Reciprocal relationship from KMDA graph: ts compete with products distributed by well-established biopharmaceutical companies, including several large competitors in the plasma industry. These large … |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BIOTEST-AG | BIOTEST-AG | 85% | he out-licensing of ASCENIV to Biotest AG (“Biotest”) in 2012 to market and sell this product in Europe and certain countries in Northern Africa and the Middle East. Biotest has provided the Company … |
| PRIORITY-HEALTHCARE-DISTRIBUTION-INC | PRIORITY-HEALTHCARE-DISTRIBUTION-INC | 85% | ioCare”) and Priority Healthcare Distribution, Inc. d/b/a CuraScript SD Specialty Distribution (“Curascript”), represented an aggregate of approximately 71% and 64%, respectively, of our consolidated… |
| STT-PG | State Street Corporation | 72% | o the manufacture and marketing of our products and product candidates may result in significant criminal and/or civil sanctions, including jail sentences, fines or exclusion from participation in ap… |
| STT-PG | State Street Corporation | 72% | Reciprocal relationship from STT-PG graph: Reciprocal relationship from ADMA graph: o the manufacture and marketing of our products and product candidates may result in significant criminal and/or ci… |
| ADMA-BIOCENTERS-GEORGIA-INC | ADMA-BIOCENTERS-GEORGIA-INC | 62% | h equivalents - end of period $ 138,153 $ 71,625 The accompanying notes are an integral part of these condensed consolidated financial statements. 4 Index ADMA BIOLOGICS, INC. AND SUBSIDIARIES NOTES … |
| ADMA-BIOMANUFACTURING-LLC | ADMA-BIOMANUFACTURING-LLC | 62% | h equivalents - end of period $ 138,153 $ 71,625 The accompanying notes are an integral part of these condensed consolidated financial statements. 4 Index ADMA BIOLOGICS, INC. AND SUBSIDIARIES NOTES … |
| DELAWARE-GENERAL-CORPORATION | DELAWARE-GENERAL-CORPORATION | 62% | o the manufacture and marketing of our products and product candidates may result in significant criminal and/or civil sanctions, including jail sentences, fines or exclusion from participation in ap… |
| DISPOSAL-GROUP | DISPOSAL-GROUP | 62% | ct of which is currently being evaluated. 3. INVENTORIES The following table provides the components of inventories: March 31, 2026 December 31, 2025 (In thousands) Raw materials $ 89,281 $ 96,612 Wo… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ADMA-DEBT | Debt stack $196.6M | 90% | Market cache reports total debt of $196.6M. |
| ADMA-DEBT-7511 | Warrants outstanding: 966554 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| ADMA-DEBT-7512 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2012-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| ADMA-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC | VANGUARD CAPITAL MANAGEMENT LLC | 95% | 13F/ownership overlay lists VANGUARD CAPITAL MANAGEMENT LLC; shares held 20,613,742; value $185.7B; as of 2026-03-31. |
| ADMA-OWNER-CITADEL-ADVISORS-LLC | CITADEL ADVISORS LLC | 95% | 13F/ownership overlay lists CITADEL ADVISORS LLC; shares held 6,247,242; value $56.3B; as of 2026-03-31. |
| ADMA-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | GEODE CAPITAL MANAGEMENT, LLC | 95% | 13F/ownership overlay lists GEODE CAPITAL MANAGEMENT, LLC; shares held 5,824,116; value $52.5B; as of 2026-03-31. |
| ADMA-OWNER-BLACKROCK-INC | BlackRock, Inc. | 95% | 13F/ownership overlay lists BlackRock, Inc.; shares held 36,830,774; ownership 16.44%; value $331.8B; as of 2026-03-31. |
| ADMA-OWNER-STATE-STREET-CORP | STATE STREET CORP | 95% | 13F/ownership overlay lists STATE STREET CORP; shares held 14,084,205; value $126.9B; as of 2026-03-31. |
| ADMA-OWNER-MORGAN-STANLEY | MORGAN STANLEY | 95% | 13F/ownership overlay lists MORGAN STANLEY; shares held 5,840,946; value $78.8B; as of 2026-03-31. |
| ADMA-OWNER-VANGUARD-PORTFOLIO-MANAGEMENT-LLC | VANGUARD PORTFOLIO MANAGEMENT LLC | 95% | 13F/ownership overlay lists VANGUARD PORTFOLIO MANAGEMENT LLC; shares held 8,868,657; value $79.9B; as of 2026-03-31. |
| ADMA-OWNER-CAPITAL-RESEARCH-GLOBAL-INVESTORS | Capital Research Global Investors | 95% | 13F/ownership overlay lists Capital Research Global Investors; shares held 11,191,116; value $100.8B; as of 2026-03-31. |
| ADMA-OWNER-BARCLAYS-PLC | BARCLAYS PLC | 95% | 13F/ownership overlay lists BARCLAYS PLC; shares held 5,697,200; value $64.4B; as of 2026-03-31. |
| ADMA-OWNER-NUVEEN-LLC | Nuveen, LLC | 95% | 13F/ownership overlay lists Nuveen, LLC; shares held 6,098,225; value $54.9B; as of 2026-03-31. |
| ADMA | ADMA Biologics, Inc. | 82% | Steve Elms | Managing Member | buy | 98020 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Grossman Adam S | President and CEO | sell | 2204728 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Terry Kohler | 10% Owner |
| ADMA | ADMA Biologics, Inc. | 82% | Tade Brad L. | CFO and Treasurer | sell | 6479 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Tade Brad L. | CFO and Treasurer | sell | 6479 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Grossman Adam S | President and CEO | sell | 24793 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Kaitlin M. Kestenberg | COO and SVP, Compliance | sell | 8161 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Grossman Adam S | President and CEO | sell | 15000 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Steve Elms | Managing Member | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Grossman Jerrold B | CEO | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Kaitlin M. Kestenberg | COO and SVP, Compliance | option_exercise | 91631 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Grossman Adam S | President and CEO | option_exercise | 444711 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Kwon Young | CEO | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Alison Cecily Finger | Director | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Salas Eduardo Rene | C/O ADMA BIOLOGICS, INC. | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Steve Elms | Managing Member | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Guiheen Lawrence P. | CFO | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Salas Eduardo Rene | C/O ADMA BIOLOGICS, INC. | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Alison Cecily Finger | Director | option_exercise | 17730 shares |
| ADMA | ADMA Biologics, Inc. | 82% | Kwon Young | CEO | option_exercise | 17730 shares |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| STT-PG | State Street Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| KMDA | Kamada Ltd. | 100.00 | 1 | ['supplier'] |
| ARCC | Ares Capital Corporation | 100.00 | 1 | ['supplier'] |
| ALVO | Alvotech | 50.00 | 2 | |
| CHKP | Check Point Software Technologies Ltd. | 50.00 | 2 | |
| SAR | Saratoga Investment Corp. | 50.00 | 2 | |
| FGPR | Ferrellgas Partners, L.P. | 50.00 | 2 | |
| FOSL | Fossil Group, Inc. | 50.00 | 2 | |
| FIP | FTAI Infrastructure Inc. | 50.00 | 2 | |
| GILT | Gilat Satellite Networks Ltd. | 50.00 | 2 | |
| BEKE | KE Holdings Inc. | 50.00 | 2 | |
| ARES | Ares Management Corporation | 50.00 | 2 | |
| HPK | HighPeak Energy, Inc. | 50.00 | 2 | |
| SMBC | Southern Missouri Bancorp, Inc. | 50.00 | 2 | |
| CM | Canadian Imperial Bank of Commerce | 50.00 | 2 | |
| HPAIW | Helport AI Ltd | 50.00 | 2 | |
| FFAI | Faraday Future Intelligent Electric Inc. | 50.00 | 2 | |
| ICL | ICL Group Ltd | 50.00 | 2 | |
| TKPHF | Takeda Pharmaceutical Company Limited | 50.00 | 2 | |
| TEM | Tempus AI, Inc. | 50.00 | 2 |